Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes

Diabetes.

The novel diabetes subgroups show multiple differences in biomarkers of inflammation, underlining a prominent role of inflammatory pathways in particular in SIRD.